Web Results


JAMES BANIGAN and RICHARD TEMPLIN, et al. v. ORGANON USA INC., et al. ORDER. August 23, 2016. ZOBEL, J. Before the court are two motions for ...


6 days ago ... SWEET v. ORGANON USA INC. et al (2:17-cv-08074), New Jersey District Court, Filed: 10/10/2017 - PacerMonitor Mobile Federal and ...


“Off–Label Marketing Claims Against Organon To state a claim under FCA ... Harvey Kurzweil, Suzanne Jaffe Bloom, New York, NY, for Organon USA Inc., et al.


ence 11) has resulted from the studies ofJennings et al. (12), .... on membranes ( Hybond N +; Amersham Corp., Arlington Heights, .... phosphatase-conjugated anti-IgG, IgA, IgM (Organon Teknika Co., ..... Pavliak, V., J.R. Brisson, F. Michon, D. Uhrin, and H.J. Jen- nings. .... Lesse, A.J., A.A. Campagnari, W.E. Bittner, and M.A..


Nov 11, 2009 ... |Child Adolesc Psychiatry Ment Health; |v.3; 2009; |PMC2781799 ..... All analyses were performed in SPSS version 15.0 (SPSS, Inc., Chicago, IL, USA). .... the Bror Gadelius foundation and the Organon Foundation. ... [PubMed] [Cross Ref]; Beesdo K, Bittner A, Pine D, Stein MB, Höfler M, Lieb R, Wittchen ...


May 1, 2005 ... {7} M.J. Bitner, S.W. Brown, M.L. Meuter, Technology infusion in ... Applications, and Programming, Sage Publications, Inc., Thousand Oaks, CA, 1994 ... of the end-user computing satisfaction instrument, MIS Quarterly, v.18 n.4, p.453-461, Dec. ... {35} E.T., Loiacono, R.T. Watson, D.L. Goodhue, WebQual: a ...


Aug 24, 2011 ... Recently, Newman et al. introduced the physiologic index of comorbidity ( physiologic .... Corp, Durham, NC) using a partial thromboplastin reagent ( Organon Teknika Corp). ..... Enright PL, McBurnie MA, Bittner V, et al. .... U.S. National Library of Medicine 8600 Rockville Pike, Bethesda MD, 20894 USA.


Jul 18, 2012 ... all (Gaspard et al., 2003) previous studies have suggested that oral. CCs worsen .... (EE, 20 mg and desogestrel, 150 mg; Mercilonw; Organon Ltd., Dublin,. Ireland .... software (version 15.0 for Windows, SPSS Inc., Chicago, IL, USA). Statis- ...... Kastelein JJ, Bittner V, Fruchart JC, Treating to New Targets.


Grady D, Herrington D, Bittner V, et al. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/Progestin Replacement ...